USANA Health Sciences, Inc. (NYSE:USNA – Get Rating) saw unusually-high trading volume on Friday . Approximately 1,256 shares changed hands during mid-day trading, a decline of 98% from the previous session’s volume of 68,435 shares.The stock last traded at $67.13 and had previously closed at $67.05.
Several research firms have recently commented on USNA. DA Davidson decreased their price objective on USANA Health Sciences from $86.00 to $76.00 in a research note on Wednesday, April 27th. StockNews.com cut USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Tuesday, April 26th. Finally, Jefferies Financial Group cut USANA Health Sciences from a “hold” rating to an “underperform” rating and cut their price target for the company from $78.00 to $53.00 in a report on Thursday. One analyst has rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $83.67.
The firm has a market capitalization of $1.28 billion, a P/E ratio of 12.36 and a beta of 0.77. The stock has a 50-day simple moving average of $72.16 and a two-hundred day simple moving average of $82.84.
USANA Health Sciences (NYSE:USNA – Get Rating) last announced its earnings results on Tuesday, April 26th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.14 by $0.01. USANA Health Sciences had a return on equity of 27.04% and a net margin of 9.41%. The company had revenue of $272.87 million for the quarter, compared to analyst estimates of $270.80 million. During the same period in the prior year, the company posted $1.45 EPS. Equities research analysts predict that USANA Health Sciences, Inc. will post 4.15 earnings per share for the current fiscal year.
In other news, insider Brent Neidig sold 1,400 shares of the company’s stock in a transaction dated Thursday, June 16th. The stock was sold at an average price of $70.93, for a total value of $99,302.00. Following the sale, the insider now owns 1,406 shares in the company, valued at $99,727.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.36% of the stock is owned by corporate insiders.
Large investors have recently bought and sold shares of the stock. Vanguard Group Inc. grew its position in USANA Health Sciences by 0.8% in the first quarter. Vanguard Group Inc. now owns 1,510,852 shares of the company’s stock worth $120,037,000 after acquiring an additional 12,121 shares during the period. Pzena Investment Management LLC raised its stake in USANA Health Sciences by 64.7% in the first quarter. Pzena Investment Management LLC now owns 733,939 shares of the company’s stock valued at $58,311,000 after buying an additional 288,307 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in USANA Health Sciences by 0.4% in the first quarter. Dimensional Fund Advisors LP now owns 566,420 shares of the company’s stock valued at $45,002,000 after buying an additional 2,390 shares in the last quarter. State Street Corp increased its position in shares of USANA Health Sciences by 1.8% during the first quarter. State Street Corp now owns 386,877 shares of the company’s stock worth $30,737,000 after purchasing an additional 6,817 shares in the last quarter. Finally, Invesco Ltd. increased its position in shares of USANA Health Sciences by 3.0% during the first quarter. Invesco Ltd. now owns 159,705 shares of the company’s stock worth $12,688,000 after purchasing an additional 4,604 shares in the last quarter. 55.72% of the stock is owned by hedge funds and other institutional investors.
About USANA Health Sciences (NYSE:USNA)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products.
Receive News & Ratings for USANA Health Sciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for USANA Health Sciences and related companies with MarketBeat.com’s FREE daily email newsletter.